
Thermo Fisher Scientific TMO
€ 400.05
-0.43%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Thermo Fisher Scientific P/E 2011-2026 | TMO
P/E Jährlich Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.3 | 32.5 | 36.1 | 31 | 27.7 | 27.9 | 34.6 | 33.5 | 38.1 | 28 | 26.7 | 26.3 | 32.5 | 21.7 | 15 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 38.1 | 15 | 29.4 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 16.65 | - | $ 179 M | ||
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
34.7 | $ 112.95 | -1.68 % | $ 34.3 B | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 24.09 | -2.49 % | $ 669 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 1.58 | -3.07 % | $ 2.1 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 19.97 | -8.88 % | $ 1.06 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 14.83 | -3.1 % | $ 448 M | ||
|
Illumina
ILMN
|
-13.4 | $ 123.95 | -2.34 % | $ 19.7 B | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 166.31 | -0.24 % | $ 8.24 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
-32.3 | $ 81.88 | -1.49 % | $ 10.3 B | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 81.18 | -2.84 % | $ 5.48 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.11 | -2.52 % | $ 1.98 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.96 | 1.5 % | $ 8.67 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 25.46 | -6.17 % | $ 20 B | ||
|
Personalis
PSNL
|
-3.12 | $ 5.25 | -4.55 % | $ 311 M | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 6.74 | -6.13 % | $ 281 M | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 409.82 | 0.01 % | $ 11.8 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.16 | -1.02 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 114.49 | 11.71 % | $ 9.44 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 254.56 | -1.92 % | $ 21.2 B | ||
|
Trinity Biotech plc
TRIB
|
129 | $ 0.6 | -1.75 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 57.59 | -2.65 % | $ 3.44 B | ||
|
NeoGenomics
NEO
|
-13.7 | $ 8.62 | -4.43 % | $ 1.1 B | ||
|
Celcuity
CELC
|
-30.3 | $ 118.87 | -1.0 % | $ 5.56 B | ||
|
National Research Corporation
NRC
|
27.2 | $ 15.51 | -7.9 % | $ 347 M | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.72 | -2.58 % | $ 437 M | ||
|
Natera
NTRA
|
-9.69 | $ 193.39 | -3.39 % | $ 19 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 188.31 | -3.42 % | $ 20.9 B | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M | ||
|
Exagen
XGN
|
-3.51 | $ 2.71 | -0.73 % | $ 58.4 M | ||
|
OpGen
OPGN
|
0.761 | - | -16.95 % | $ 1.54 M |